We are live on ! Find out more
CG

Carlyle Group Portfolio holdings

AUM $10.6B
1-Year Est. Return 11.25%
This Fund
S&P 500
This Quarter Est. Return
+7.47%
1 Year Est. Return
+11.25%
3 Year Est. Return
-0.47%
5 Year Est. Return
-4.92%
10 Year Est. Return
+7.54%
AUM
$3.8B
AUM Growth
-$345M
Cap. Flow
+$3.37B
Cap. Flow %
88.64%
Top 10 Hldgs %
99.33%
Holding
27
New
Increased
1
Reduced
5
Closed
4

Top Buys

Rank Stock Value
1
SARO
StandardAero Inc
SARO
+$3.4B

Sector Composition

Rank Sector Weight
1 Industrials 94.35%
2 Healthcare 2.64%
3 Technology 1.87%
4 Real Estate 0.69%
5 Communication Services 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REPX icon
26
Riley Exploration Permian
REPX
$759M
-9,880
Closed -$315K
SYRE icon
27
Spyre Therapeutics
SYRE
$8.7B
-9,620
Closed -$224K

Similar funds

Carlyle Group's Q1 2025 Portfolio in Review

As of Q1 2025, Carlyle Group held 27 positions worth $3.8B, down 8.3% from $4.15B the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Carlyle Group deployed $3.37B of net new capital in Q1 2025, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Industrials at 94% of assets, up from 94% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Soleno Therapeutics, an estimated $25.1M trimmed.

  • Carlyle Group added most to StandardAero Inc in Q1 2025, an estimated $3.4B increase.
  • Carlyle Group's biggest Q1 2025 reduction was Soleno Therapeutics, cutting an estimated $25.1M.
  • Carlyle Group fully exited Riley Exploration Permian in Q1 2025, selling an estimated $315K.
  • Carlyle Group's ten largest holdings make up 99% of its $3.8B portfolio in Q1 2025.
  • Carlyle Group opened 0 new positions and closed 4 in Q1 2025.
  • Carlyle Group's portfolio value fell 8.3% quarter-over-quarter to $3.8B.

Based on Carlyle Group's 13F filing for Q1 2025, filed 9 May 2025.